Bansisons Tea Industries Ltd — Important, 01-06-2026: Company Update

Novyra Pharmachem Limited's board seeks shareholder approval for key items. A major proposal involves a capital reduction to address accumulated losses of 5.71 Cr. The plan will reduce paid-up equity capital from 6.33 Cr to 0.90 Cr by canceling approximately 85.71% of existing shares, effectively one share for every seven held. This restructuring aims to present a true financial picture, streamline the balance sheet, and enhance the company's ability to raise funds and explore dividend opportunities. Shareholders will also vote on re-appointing Mr. Sandeep Agarwal and regularizing and appointing Mr. Anilkumar Amreliya as Managing Director for five years at a salary of Rs. 11,000 per month.